Suchergebnisse - "Han, Bao-Hui"

PubPharm (73)

1

First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1% : results from a multicenter, open-label, phase 2 trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Ren, S. | Wang, X. | Han, B. | +19

2

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors

enthalten in: BMC medicine | 2022

von Nie, W. | Wang, Z. | Zhang, K. | +12

3

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors

enthalten in: BMC medicine | 2022

von Nie, W. | Wang, Z. | Zhang, K. | +12

4

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors

enthalten in: BMC medicine | 2022

von Nie, W. | Wang, Z. | Zhang, K. | +12

5

DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation

enthalten in: Acta pharmacologica Sinica | 2022

von Nie, W. | Hu, M. | Zhang, Q. | +11

6

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

enthalten in: Oncoimmunology | 2021

von Nie, W. | Gan, L. | Wang, X. | +17

7

Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer

enthalten in: Chinese medical journal | 2020

von Qian, F. | Han, B.

8

Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells

enthalten in: Acta pharmacologica Sinica | 2020

von Zhang, L. | Lu, J. | Liu, R. | +11

9

Anlotinib or platinum-pemetrexed as second-line therapy in EGFR T790M-negative lung cancer

enthalten in: Annals of palliative medicine | 2020

von Zhong, R. | Xu, J. | Lou, Y. | +3

10

Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2020

von Nie, W. | Xu, M. | Gan, L. | +13

1
2
3
4
5
6
7
8
Nächster »
[8]